Qualigenix handles podiatry billing, coding, and denial management for Solo, group & multispecialty foot and ankle practices, and we can show you the receipts. Corrected Q-modifier logic, class-finding documentation, and depth-based debridement coding are where podiatry money leaks, and they are exactly what we fix.
Qualigenix is a US-based revenue cycle management company that bills podiatry for independent foot and ankle practices across 48 states. Podiatry is one of the most denial-prone specialties because routine foot care, nail debridement, and wound care each carry coverage rules most billing teams apply loosely. We assign coders who work podiatry specifically, verify Medicare coverage and class findings before the claim goes out, and code debridement to the documented depth. On recent engagements, that meant a denial rate cut from 19% to 6%, first-pass acceptance up from 82% to 96%, and $214,000 in aged A/R recovered. Start with a free AR review at 786-259-0231.
11720, 11721, 11055–11057 need a qualifying systemic condition, class findings, and the correct Q7, Q8, or Q9 modifier. Miss any one, and Medicare reads the service as non-covered, not as an error to fix.
Billed inside the 60-day window, it trips a frequency edit and denies.
11042 for skin and subcutaneous where 11043 for muscle and fascia was documented either denies or underpays.
An E/M billed with a procedure on the same day gets bundled when modifier 25 is missing.
Qualigenix bills podiatry claims through a front-end prevention layer first, then clean coding, then disciplined follow-up, so problems are caught before the claim goes out rather than appealed after it is denied.
We check benefits and payer coverage rules, including Medicare LCDs for routine foot care, so coverage is confirmed before services are rendered.
Procedures that require authorization are cleared up front, not discovered at denial.
Diagnosis-to-CPT pairing for at-risk foot care, correct Q7/Q8/Q9 logic, depth-based debridement coding tied to the operative note, and disciplined use of modifiers 25 and 59/XS.
Claims are checked against payer edits, then submitted and tracked.
Medicare crossover to secondaries is posted, and small patient balances are billed rather than written off.
Denials are worked by payer and denial reason, with appeal templates mapped to each reason code.
A 3-provider podiatry group with roughly 60% Medicare payer mix carried $412,000 in A/R, 38% of it past 120 days. Routine foot care claims (11720, 11721, 11055–11057) had stalled on inconsistent Q7/Q8/Q9 modifiers and class-finding documentation, so payers held or partially paid and nobody worked the remainder. Medicare crossover to secondaries was not being posted, and small patient balances were written off.
We ran a full A/R aging segmentation, worked claims by payer and denial reason rather than by date, rebilled the stalled routine-care claims with corrected modifiers, and reactivated secondary and crossover billing.
A solo podiatrist coding 320 encounters a month was stuck at 82% first-pass acceptance. Routine foot care went out without the systemic-condition diagnosis pairing and class findings Medicare requires, so it read as non-covered. Wound debridement was coded to the wrong depth (11042 for skin and subcutaneous where the note supported 11043 for muscle and fascia). Same-day E/M with a procedure went out without modifier 25 and got bundled.
We rebuilt the coding workflow: diagnosis-to-CPT pairing rules for at-risk foot care, correct Q-modifier logic, depth-based debridement coding tied to the operative note, and disciplined use of modifiers 25 and 59/XS.
A 2-location podiatry practice sat at a 19% denial rate, mostly Medicare routine-foot-care and nail-debridement rejections. The denials clustered in three buckets: medical-necessity rejections on routine foot care (missing qualifying diagnosis and class findings), frequency-edit denials on nail debridement billed inside the 60-day window, and missing Q modifiers that flagged services as non-covered.
We built a front-end denial-prevention layer, checking eligibility and coverage against payer LCDs before claims went out, plus a structured appeal workflow with documentation templates mapped to each denial reason.
Qualigenix codes the podiatry procedures that drive both volume and denials, tied to the documentation each one requires.
11720 and 11721 (nail debridement), 11055, 11056, 11057 (paring or cutting of benign hyperkeratotic lesions), paired with a qualifying systemic diagnosis and class findings, and the correct Q7, Q8, or Q9 modifier.
Qualigenix keeps podiatry billing compliant by coding to the documentation, applying Medicare coverage rules as written, and monitoring for over- and undercoding on every claim. Underbilling leaves money on the table. Overbilling invites audits and penalties. We bill what the note supports, no more and no less, and we hold a 98.6% compliance and audit pass rate with an over/undercoding rate under 2%. All work is HIPAA compliant, with patient data handled under strict security controls.
We pair podiatry-specific coders with revenue cycle processes that hold up. Coders stay current with payer rules, coding updates, and regulatory changes so claims are accurate and reimbursement holds.
Still weighing it? A quick call answers the cost and denial questions for your practice.
Podiatry billing services handle the full revenue cycle for foot and ankle practices: eligibility, coding, claim submission, denial appeals, and AR follow-up, using coders who know podiatry-specific rules like Q-modifiers, class findings, and debridement depth. Qualigenix provides this remotely for practices across 48 states, and most start with a free AR review.
Outsource when denials, aged AR, or coding gaps are costing more than a billing team would, or when you can't keep coders current on podiatry LCDs. Outsourcing removes staffing, training, and software cost while adding specialty coders. In-house can work for high-volume groups with dedicated, certified podiatry coders. A free AR review shows which case your practice is in.
Routine foot care (11055–11057, 11719–11721) with Q7/Q8/Q9 and class findings, nail and wound debridement (11042/11043, 11720/11721) coded to documented depth, surgical codes such as bunionectomy (28296) and hammertoe correction (28285), and correct use of modifiers 25, 59, and the X-modifiers. Coders update coding rules with each annual CPT and ICD-10 release.
It depends on the size and age of the backlog, but the podiatry AR cleanups we run have cut AR past 120 days from 38% to 14% in 90 days. The AR review estimates the recoverable amount before any work starts.
Look for coders who specialize in podiatry rather than general medical billing, a documented first-pass clean claim rate, an active denial-appeal process, and transparent reporting. Ask for their denial rate and days-in-AR numbers with denominators. Qualigenix runs a 98.2% first-pass rate and 4.8% denial rate, and will review your current AR before you commit.
Most podiatry billing is priced as a percentage of collections, so the fee scales with what's actually recovered rather than a flat retainer. The number that matters is net collections after fees. Qualigenix scopes pricing against your volume and payer mix after the AR review. Call 786-259-0231.
Yes. Qualigenix bills Medicare, state Medicaid programs, and commercial payers, checking claims against payer LCDs and frequency edits before submission and posting Medicare crossover to secondaries. Eligibility is verified pre-visit to prevent coverage-based denials.